SecBot SecBot
SC 13G/A ·Filed Nov 10, 2026

PHAT

Phathom Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 9h ago SEC0000914208-26-000448
Passive stake amendment
Actionable Insight • Neutral

Invesco's stake is negligible and unchanged in any material way. No action warranted; the filing is routine.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$6.28
T+0 close · Nov 10, 2026 · via day close
Latest settled
−0.80%
T+1 · $6.23
Vs SPY
−0.44%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 11 $6.28entry
  2. T+1 · 5d ago −0.80%α −0.44% · $6.23
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Invesco Ltd. filed an amendment to its Schedule 13G for Phathom Pharmaceuticals, reporting beneficial ownership of 30,562 shares as of September 30, 2026, down from 30,223 shares in the prior filing. The stake remains well below 5% and represents a negligible change, indicating routine portfolio adjustment rather than a material shift in conviction.

Key Financial Metrics

Stake
0%
Investor
Invesco Ltd.
Investor Type
mutual fund

Key Facts

  • Invesco Ltd. reported beneficial ownership of 30,562 shares of Phathom Pharmaceuticals as of September 30, 2026.
  • The prior filing (July 2026) reported 30,223 shares; the increase is 339 shares, or approximately 1.1%.
  • The stake represents 0.0% of shares outstanding per the filing.
  • Invesco disclaims beneficial ownership of shares held for clients and certifies passive intent under Rule 13d-1(b).

Financial Impact

Stake value approximately $44,000 based on market cap of $427M and 0.0% ownership; change is immaterial.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000914208-26-000448
Document: 0000914208-26-000448-index.html0000914208-26-000448
Document: 0000914208-26-000448.txt0000914208-26-000448

Track record

16 reports on PHAT

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +36.43% at T+60 after the Jul 30, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Viewing Entry $6.28 Now $5.88 −6.37% settles Nov 18
  2. Nov 2, 202614d ago SC 13D/A Neutral 3/10 Entry $5.74 to $5.45 Now $5.88 +2.44% ▼ −5.14% −4.55% vs SPY
  3. Oct 29, 202618d ago 8-K Bullish 6/10 No price data
  4. Oct 29, 202618d ago Press Release Bullish 5/10 Entry $6.22 to $5.08 Now $5.88 −5.47% ▼ −18.33% −13.60% vs SPY
  5. Oct 26, 202621d ago 8-K Bearish 5/10 Entry $5.94 to $5.74 Now $5.88 +1.01% ▲ +3.37% +2.11% vs SPY
  6. Oct 23, 202624d ago 8-K Bearish 6/10 Entry $5.94 to $5.74 Now $5.88 +1.01% ▲ +3.37% +2.11% vs SPY
  7. Oct 19, 202628d ago Press Release Neutral 1/10 Entry $7.01 Now $5.88 −16.12% No price data
  8. Sep 29, 20266w ago 8-K Neutral 4/10 Entry $7.30 to $6.81 Now $5.88 −19.45% ▼ −6.71% −8.63% vs SPY
  9. Jul 30, 202615w ago 8-K Mixed 5/10 No price data
  10. Jul 30, 202615w ago Press Release Bearish 6/10 Entry $9.03 to $8.39 Now $5.88 +34.88% ▲ +7.09% +10.71% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026